The largest database of trusted experimental protocols

Combur 10 test d dipstick

Manufactured by Roche
Sourced in Germany, Switzerland

The Combur 10 Test®D dipstick is a laboratory analysis tool used for the rapid and semi-quantitative detection of various analytes in urine samples. It is designed to simultaneously detect up to 10 different parameters, including glucose, protein, blood, pH, and other urinary constituents.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using combur 10 test d dipstick

1

Healthy Urine Samples Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
First morning urine samples were collected from nine healthy volunteers, unless otherwise specified, ranging from 24 to 57 years of age (Five males and four females). Samples were tested by Combur 10 Test®D dipstick (Roche Diagnostics; Mannheim, Germany) and values were within normal range or negative. Coordinating Ethics Committee, Hospital District of Helsinki and Uusimaa, Finland, approved the study with following number: 114/13/03/00/16. Written informed consent was obtained from the healthy volunteers. All methodology complies with the relevant guidelines and regulations.
+ Open protocol
+ Expand
2

Evaluating Urine Biomarkers in Diabetic Nephropathy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Control urine samples were collected from twelve healthy volunteers among the laboratory staff, aged 20–40, in accordance with ethical protocols of the Dublin City University. First morning void urine was processed within 3 h without addition of protease inhibitors. Urine was anonymously tested by Combur 10 Test D dipstick (Roche Diagnostics, Basel, Switzerland) for the following: specific gravity, leucocytes, nitrites, proteins, glucose, ketones, urobilinogen, bilirubin, blood, and haemoglobin.
All patients participated in the Finnish Diabetic Nephropathy (FinnDiane) study, a nationwide multicenter study with the aim of identifying genetic and clinical risk factors for diabetic nephropathy in type 1 diabetes. The study protocol is in accordance with the Declaration of Helsinki, and it has been approved by the local ethics committee in each participating study centre. Urinary albumin excretion rate (AER) was determined in 24 h urine collections by immunoturbidimetry (Pharmacia, Uppsala, Sweden). The renal status was defined based on AER in at least two of three collections. Patients were divided by AER categorically.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!